AlphaSorb-C™
NOW PRODUCT #: 0726
UPC: 733739007261-
NOW ® AlphaSorb-C™
is a patent-pending formulation that combines
the benefits of buffered vitamin C (ascorbate)
with other antioxidants to create a product that
specifically enhances ascorbate absorption,
especially via the important glucose transport
pathways. This makes AlphaSorb-C™ uniquely
beneficial to the many millions of people with
insulin resistance, or poor insulin sensitivity,
who are prone to have poor ascorbate status, as
well as for everyone seeking to improve vitamin
C uptake into the bloodstream and cells.
AlphaSorb-C™ is a nature-identical formulation
designed to provide an alternative to the
popular types of vitamin C developed years ago.
It is available in a non-acidic, gentle form.
The decision to make these product advancements was based on a number of
factors. Ultimately, the most innovative new formulas are being brought to the
market as a result of ongoing research and advanced technology. Much has been
learned about how vitamin C functions within the body, as well as which
conditions provide the most optimal environment for its absorption and
utilization. Over the past two years, NOW researchers closely monitored these
findings in order to develop a formula that would set new standards for the
efficacy of vitamin C and function-boosting co-factors.
One significant finding involves the unique absorption abilities of threonic acid – a metabolite of ascorbic acid. An article published in the October 2007 Medical Science Monitor provided convincing evidence of the compound's unique absorption abilities in a double-blind, placebo-controlled clinical study that concluded threonic acid had two very beneficial characteristics: First, it increases the amount of vitamin C that it is taken up by the immune system's T-cells; Secondly, it increases vitamin C's overall potency within the cells.
Based on these clinical studies and other scientific information, many vitamin C and Ester-C™ users are now turning to threonic acid-containing formulas as a potent source of cellular protection. These findings, coupled with growing public interest in the potential of vitamin C metabolites, inspired NOW to develop AlphaSorb-C™. Realizing that absorption and utilization of vitamin C were key benefits that had to be provided by any new formulation, a theory was developed suggesting that vitamin C could be transported via active glucose transport pathways. This theory was found to be valid, and it was determined that the transport mechanism could be enhanced through proper formulation.
Human cell laboratory work demonstrated the benefits of AlphaSorb-C™ over ascorbic acid and a United States patent was applied for, specifically for the purpose of recognizing the compound's unique mechanism of action. The efficacy of AlphaSorb-C™ is based on the unique combination of a non-acidic vitamin C plus certain metabolites, notably threonic acid and alpha lipoic acid.
The known benefits of non-acidic vitamin C and metabolites are combined with substances that stimulate vitamin C transport into cells, enhancing absorption into both the bloodstream and immune cells, while stimulating utilization by immune cells. Additionally, because of the ability of AlphaSorb-C™ to enhance vitamin C absorption via glucose transport channels, it is an ideal and suitable source of vitamin C for diabetics and those with blood sugar imbalances; individuals who traditionally struggle when it comes to maintaining healthy vitamin C levels.
Studies have determined that alpha lipoic acid may enhance the body's ability to better utilize vitamin C in other ways, such as enhancing absorption through glucose pathways into cells, thus stimulating utilization in repair and protection activities. * Finally, this innovative new nature-identical vitamin C formula from NOW is 100% vegetarian, and has been enhanced with synergistic bioflavonoids to ensure that its active constituents are well-absorbed and highly effective. NOW ® AlphaSorb-C™ is the culmination of ongoing advanced scientific research.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
References:
1. Weeks BS, Perez PP. Absorption rates and free radical scavenging values of
vitamin C-lipid metabolites in human lymphoblastic cells. Med Sci Monitor. 2007
Oct; 13(10):BR205-10.
2. Internal Study, NOW Foods, 2007
3. Rowe DJ, Ko S, Tom XM, Silverstein SJ, Richards DW. Enhanced production of
mineralized nodules and collagenous proteins in vitro by calcium ascorbate
supplemented with vitamin C metabolites. Jour Periodontal. 1999 Sep;70(9):992-9
4. Constantinescu A, Tritschler H, Packer L. Alpha-Lipoic acid protects against
hemolysis of human erythrocytes induced by peroxyl radicals. Biochem Mol Biol
Int. 1994 Jul;33(4):669-79.
5. U.S. Patent Application: 1, Serial #11,877,230
Homepage